These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 8236027)

  • 1. A thromboxane A2 synthetase inhibitor, OKY-046, reduces liver damage in hepatectomy.
    Shimada M; Matsumata T; Shirabe K; Sugimachi K
    Surgery; 1993 Nov; 114(5):993-5. PubMed ID: 8236027
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of prostanoid in hepatic damage during hepatectomy.
    Shirabe K; Takenaka K; Yamamoto K; Kitamura M; Itasaka H; Matsumata T; Shimada M; Sugimachi K
    Hepatogastroenterology; 1996; 43(9):596-601. PubMed ID: 8799402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary excretion of prostaglandins and renal function after hepatic resection.
    Matsumata T; Yamamoto K; Shirabe K; Shimada M; Sugimachi K; Takesue F; Muto Y; Ikeda T
    Hepatogastroenterology; 1997; 44(15):774-8. PubMed ID: 9222688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Experimental study on the prevention of vasospasm following subarachnoid hemorrhage by a thromboxane A2 synthetase inhibitor, OKY-046].
    Ohsugi S
    Nihon Geka Hokan; 1986 Mar; 55(2):297-305. PubMed ID: 3827476
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effects of a selective thromboxane A2 synthetase inhibitor, OKY-046, on proteinuria of aminonucleoside nephrotic rats].
    Suzuki S; Akama H; Kume K; Higuchi E; Kamiyama S; Suzuki J; Ohara N; Yugeta E; Kato K; Suzuki H
    Nihon Jinzo Gakkai Shi; 1988 Apr; 30(4):341-6. PubMed ID: 3230687
    [No Abstract]   [Full Text] [Related]  

  • 6. Thromboxane A2 synthetase inhibitor (OKY-046) improves abnormal mucociliary transport in asthmatic patients.
    Kurashima K; Ogawa H; Ohka T; Fujimura M; Matsuda T
    Ann Allergy; 1992 Jan; 68(1):53-6. PubMed ID: 1736720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Thromboxane A2 synthetase inhibitor in asthma therapy].
    Machida K; Takagi K; Horiba M
    Nihon Rinsho; 1996 Nov; 54(11):3034-9. PubMed ID: 8950950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of thromboxane A2 synthetase inhibitor (OKY-046) on leukotriene C4-induced airway hyperresponsiveness in guinea pigs].
    Tsukagoshi H; Yodonawa S; Kurosawa M
    Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Jun; 31(6):707-11. PubMed ID: 8345703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prevention of vasospasm following subarachnoid hemorrhage using a thromboxane A2 synthetase inhibitor (OKY-046)--clinical study among multiple institutions].
    Yonekawa Y; Handa H; Okamoto S; Ohta T; Kamijo Y; Oda Y; Kondo A; Nin K; Yamamoto T; Ban S
    Nihon Geka Hokan; 1986 May; 55(3):473-84. PubMed ID: 3541826
    [No Abstract]   [Full Text] [Related]  

  • 10. Beneficial effect of thromboxane A2 synthetase inhibitor (OKY-046) on 24-hr simple hypothermic preservation of the canine pancreas graft.
    Nagami H; Tamura K; Kin S; Teramoto M; Ishida T
    Int Surg; 1995; 80(3):274-7. PubMed ID: 8775620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical study on effect of thromboxane A2 synthetase inhibitor (OKY-046) to clarify the regulation of cerebral blood flow in cerebral thrombosis.
    Nihei C; Metoki H; Shimanaka Y; Kawahara R; Komatsu O; Oike Y; Kanazawa T; Izawa M; Kaneko H; Hoshi Y
    Adv Prostaglandin Thromboxane Leukot Res; 1987; 17B():953-7. PubMed ID: 2960210
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibition of antigen-induced airway hyperresponsiveness by a thromboxane synthetase inhibitor (OKY-046) in allergic dogs.
    Chung KF; Aizawa H; Becker AB; Frick O; Gold WM; Nadel JA
    Am Rev Respir Dis; 1986 Aug; 134(2):258-61. PubMed ID: 3509981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Thromboxane A2 metabolism and clinical effects of selective thromboxane A2 synthetase inhibitor in patients with chronic glomerulonephritis].
    Niwa T; Nomura T; Ozawa Y; Maeda K; Shibata M
    Nihon Jinzo Gakkai Shi; 1987 Jun; 29(6):655-65. PubMed ID: 3682335
    [No Abstract]   [Full Text] [Related]  

  • 14. [Protective effect of a thromboxane synthetase inhibitor, OKY-046, in patients with acute respiratory failure].
    Sakio H; Usui Y; Mita H; Onoda N; Iida M; Okuda C
    Masui; 1984 Sep; 33(9):964-9. PubMed ID: 6542601
    [No Abstract]   [Full Text] [Related]  

  • 15. Hemodynamic analysis of post-reperfusion syndrome and the effect of preventing this syndrome using thromboxane A2 synthetase inhibitor (OKY-046) in swine liver transplantation.
    Ishine N; Yagi T; Ishikawa T; Sasaki H; Nakagawa K; Tanaka N
    Transplant Proc; 1997; 29(1-2):378-81. PubMed ID: 9123045
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of selective thromboxane synthetase inhibitor OKY-046 on plasma prostaglandins in patients with coronary artery disease during exercise.
    Shikano M; Ogawa K; Ito T; Chen LS; Ito Y; Imaizumi M; Uno T; Tsutsumi S; Satake T
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 13():375-7. PubMed ID: 3159226
    [No Abstract]   [Full Text] [Related]  

  • 17. [The efficacy of prostacyclin (PGI2) and/or OKY-046, a specific thromboxane synthetase inhibitor, in acute myocardial infarction--experimental study].
    Moriuchi M
    Kokyu To Junkan; 1984 Sep; 32(9):955-61. PubMed ID: 6393261
    [No Abstract]   [Full Text] [Related]  

  • 18. The combined use of prostaglandin I2 analogue (OP-2507) and thromboxane A2 synthetase inhibitor (OKY-046) strongly inhibits atherosclerosis of aortic allografts in rats.
    Hirano T; Nakafusa Y; Kawano R; Motoyama K; Arima T; Sugitani A; Tanaka M
    Surgery; 2001 May; 129(5):595-605. PubMed ID: 11331452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antithromboxane drug in the treatment of preeclampsia.
    Furuhashi N; Tsujiei M; Kimura H; Okamura K; Yajima A
    Gynecol Obstet Invest; 1991; 32(3):164-6. PubMed ID: 1756996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical effects of selective thromboxane A2 synthetase inhibitor in patients with nephrotic syndrome.
    Niwa T; Maeda K; Shibata M; Yamada K
    Clin Nephrol; 1988 Nov; 30(5):276-81. PubMed ID: 3214971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.